Get the Stockscreener App
1.04
3.53%
-0.038
Evogene Ltd stock is traded at $1.04, with a volume of 17,831.
It is down -3.53% in the last 24 hours and up +0.48% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
See More
Previous Close:
$1.078
Open:
$1.1
24h Volume:
17,831
Relative Volume:
0.37
Market Cap:
$9.07M
Revenue:
$6.74M
Net Income/Loss:
$-14.74M
P/E Ratio:
-0.4624
EPS:
-2.2491
Net Cash Flow:
$-18.31M
1W Performance:
+1.96%
1M Performance:
+0.48%
6M Performance:
-18.75%
1Y Performance:
-32.47%
1-Day Range:
$1.04
$1.10
1-Week Range:
$1.01
$1.10
52-Week Range:
$0.93
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.04 | 9.40M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.38 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
757.42 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
845.68 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
351.94 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.98 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Aug Retail: Is Evogene Ltd attractive for institutional investorsJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - baoquankhu1.vn
Jobs Data: How cyclical is SHOTWs revenue stream2025 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
S P Trends: Is McDonalds Corporation stock technically oversoldIndex Update & Reliable Intraday Trade Alerts - baoquankhu1.vn
MACD Signal: Can Evogene Ltd disrupt its industryPortfolio Risk Report & Safe Swing Trade Setups - baoquankhu1.vn
Evogene Announces CFO Resignation and Finance Leadership Transition - TipRanks
Evogene announces CFO resignation and interim appointment By Investing.com - Investing.com Nigeria
Evogene announces CFO resignation and interim appointment - Investing.com
Evogene (NASDAQ: EVGN) plans CFO change as VP Finance steps up to new role - Stock Titan
Evogene Ltd. Announces CFO Changes - marketscreener.com
Breakout Watch: Is Evogene Ltd stock heavily shortedJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn
US Market Wrap: How Evogene Ltd stock performs in weak economyNew Guidance & Expert Verified Stock Movement Alerts - Bộ Nội Vụ
Published on: 2026-01-11 04:12:19 - Улправда
Portfolio Shifts: Can Evogene Ltd stock sustain market leadershipDividend Hike & Low Risk Entry Point Guides - moha.gov.vn
HOKA Model Insights: Will Evogene Ltd. stock benefit from upcoming earnings reportsTrail vs Road Selection & updated model highlights and notes - Улправда
Is Evogene Ltd. stock undervalued vs historical averages2025 Buyback Activity & Weekly Watchlist for Hot Stocks - Улправда
Why Evogene Ltd. stock appeals to dividend seekers2025 EndofYear Setup & Real-Time Volume Spike Alerts - Улправда
Is Evogene Ltd. stock attractive for growth ETFsQuarterly Earnings Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Will Evogene Ltd. stock remain a Wall Street favoriteJuly 2025 Reactions & Weekly High Return Opportunities - Улправда
Is Evogene Ltd. stock attractive for hedge fundsWeekly Trade Summary & AI Driven Price Predictions - Улправда
Evogene, Unravel Biosciences announce scientific collaboration - TipRanks
How Evogene Ltd. stock compares to industry benchmarksInterest Rate Changes & Affordable Portfolio Growth - ulpravda.ru
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders - Finviz
Evogene (NASDAQ:EVGN) Stock Passes Below Fifty Day Moving Average – Time to Sell? - Defense World
Panic Selling: Will Evogene Ltd stock remain a Wall Street favorite2025 Price Targets & Low Drawdown Trading Strategies - moha.gov.vn
Evogene Appoints Dr. Olga Nissan as Vice President of Business Development to Drive AI-Driven Growth - The Globe and Mail
Evogene appoints Dr. Olga Nissan as VP of business development By Investing.com - Investing.com Nigeria
Evogene appoints Nissan as VP of Business Development - TipRanks
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development - Finviz
Evogene appoints Dr. Olga Nissan as VP of business development - Investing.com
Is Evogene Ltd. stock resilient to inflationJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Will Evogene Ltd. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & AI Based Trade Execution Alerts - DonanımHaber
Can Evogene Ltd. stock sustain market leadershipWeekly Gains Report & Safe Capital Investment Plans - DonanımHaber
Can Evogene Ltd. stock sustain free cash flow growth2025 Price Momentum & Entry and Exit Point Strategies - DonanımHaber
Should I hold or sell Evogene Ltd. stock in 20252025 Volume Leaders & Technical Buy Zone Confirmation - Улправда
Will Evogene Ltd. stock keep outperforming rivalsWeekly Stock Recap & Growth Focused Investment Plans - Улправда
Reviewing Vera Therapeutics (NASDAQ:VERA) & Evogene (NASDAQ:EVGN) - Defense World
Will Introduced Innovation Sustain VLS Finance Limiteds GrowthInterest Rate Changes & Superior Trading Strategies - earlytimes.in
Investment Recap: Is Evogene Ltd stock a smart buy before Fed meetingTrade Entry Report & Free Growth Oriented Trading Recommendations - BỘ NỘI VỤ
Evogene (NASDAQ:EVGN) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World
How AI Is Breaking Down the Bottlenecks in Small Molecule Drug Discovery - Unite.AI
Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
Evogene (NASDAQ:EVGN) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) - Aktiellt
Evogene shares climb 5% as cost reductions help deliver earnings beat - MSN
Evogene Ltd. Reports Strategic Shift and Financial Results - MSN
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):